[{"address1": "135 Route 202/206", "address2": "Suite 6", "city": "Bedminster", "state": "NJ", "zip": "07921", "country": "United States", "phone": "646 440 9333", "website": "https://www.intracellulartherapies.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company that develops and commercializes therapeutics and small molecule drugs for central nervous system (CNS), neuropsychiatric, and neurological disorders. The company offers CAPLYTA for the treatment of schizophrenia and bipolar depression in adults. It distributes its products through third-party wholesale drug distributors. The company was founded in 2002 and is based in Bedminster, New Jersey. As of April 2, 2025, Intra-Cellular Therapies, Inc. operates as a subsidiary of Johnson & Johnson Innovative Medicine.", "fullTimeEmployees": 860, "companyOfficers": [{"maxAge": 1, "name": "Dr. Sharon  Mates Ph.D.", "age": 71, "title": "Co-Founder, Chairman & CEO", "yearBorn": 1953, "fiscalYear": 2024, "totalPay": 3305560, "exercisedValue": 34519356, "unexercisedValue": 28546800}, {"maxAge": 1, "name": "Mr. Michael I. Halstead J.D.", "age": 51, "title": "President", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 1359027, "exercisedValue": 5115857, "unexercisedValue": 1529688}, {"maxAge": 1, "name": "Mr. Sanjeev  Narula", "age": 62, "title": "Executive VP, CFO & Treasurer", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 665479, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Suresh K. Durgam M.D.", "age": 54, "title": "Executive VP & Chief Medical Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1211319, "exercisedValue": 3159572, "unexercisedValue": 7005471}, {"maxAge": 1, "name": "Mr. Mark  Neumann", "age": 60, "title": "EVP & Chief Commercial Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 1256734, "exercisedValue": 714774, "unexercisedValue": 319980}, {"maxAge": 1, "name": "Dr. Robert E. Davis Ph.D.", "age": 73, "title": "Senior VP & Chief Scientific Officer", "yearBorn": 1951, "fiscalYear": 2024, "totalPay": 646124, "exercisedValue": 0, "unexercisedValue": 169900}, {"maxAge": 1, "name": "Mr. Juan Fernando Sanchez M.D.", "age": 53, "title": "Vice President of Corporate Communications & Investor Relations", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 296753, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Karen Patruno Sheehy Esq.", "age": 62, "title": "Senior VP & Chief Compliance Officer", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "John P. Condon", "title": "Senior VP, General Counsel & Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Olchaskey Pharm.D.", "title": "Senior VP & Head of Regulatory Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 6, "compensationRisk": 3, "shareHolderRightsRisk": 7, "overallRisk": 5, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 131.87, "open": 131.92, "dayLow": 131.87, "dayHigh": 131.87, "regularMarketPreviousClose": 131.87, "regularMarketOpen": 131.92, "regularMarketDayLow": 131.87, "regularMarketDayHigh": 131.87, "payoutRatio": 0.0, "beta": 0.462, "forwardPE": 507.19232, "volume": 16042154, "regularMarketVolume": 16042154, "averageVolume": 3621742, "averageVolume10days": 2804360, "averageDailyVolume10Day": 2804360, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 14047055872, "fiftyTwoWeekLow": 64.09, "fiftyTwoWeekHigh": 131.98, "priceToSalesTrailing12Months": 20.631586, "fiftyDayAverage": 129.4194, "twoHundredDayAverage": 92.6652, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 13037381632, "profitMargins": -0.109680004, "floatShares": 104819158, "sharesOutstanding": 106522000, "sharesShort": 2668668, "sharesShortPriorMonth": 2308425, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0251, "heldPercentInsiders": 0.02483, "heldPercentInstitutions": 0.96449995, "shortRatio": 1.2, "shortPercentOfFloat": 0.0254, "impliedSharesOutstanding": 106522000, "bookValue": 10.81, "priceToBook": 12.198889, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -74676000, "trailingEps": -0.73, "forwardEps": 0.26, "enterpriseToRevenue": 19.149, "enterpriseToEbitda": -112.185, "52WeekChange": 1.0362878, "SandP52WeekChange": 0.059571505, "quoteType": "EQUITY", "currentPrice": 131.87, "targetHighPrice": 132.0, "targetLowPrice": 132.0, "targetMeanPrice": 132.0, "targetMedianPrice": 132.0, "recommendationMean": 2.57143, "recommendationKey": "hold", "numberOfAnalystOpinions": 5, "totalCash": 1001065984, "totalCashPerShare": 9.415, "ebitda": -116213000, "totalDebt": 16981000, "quickRatio": 5.7, "currentRatio": 6.356, "totalRevenue": 680851968, "debtToEquity": 1.479, "revenuePerShare": 6.602, "returnOnAssets": -0.06964, "returnOnEquity": -0.085839994, "grossProfits": 387768000, "freeCashflow": -63549624, "operatingCashflow": -73177000, "revenueGrowth": 0.508, "grossMargins": 0.56953, "ebitdaMargins": -0.17069, "operatingMargins": -0.14655, "financialCurrency": "USD", "symbol": "ITCI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChange": 0.0, "regularMarketDayRange": "131.87 - 131.87", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 3621742, "fiftyTwoWeekLowChange": 67.78, "fiftyTwoWeekLowChangePercent": 1.0575753, "fiftyTwoWeekRange": "64.09 - 131.98", "fiftyTwoWeekHighChange": -0.11000061, "fiftyTwoWeekHighChangePercent": -0.00083346426, "fiftyTwoWeekChangePercent": 103.62878, "earningsTimestamp": 1740142848, "earningsTimestampStart": 1746448200, "earningsTimestampEnd": 1746793800, "earningsCallTimestampStart": 1730291400, "earningsCallTimestampEnd": 1730291400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.73, "epsForward": 0.26, "epsCurrentYear": 0.15, "priceEpsCurrentYear": 879.13324, "fiftyDayAverageChange": 2.450592, "fiftyDayAverageChangePercent": 0.018935276, "twoHundredDayAverageChange": 39.204796, "twoHundredDayAverageChangePercent": 0.42308003, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.6 - Hold", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1389105000000, "corporateActions": [], "regularMarketTime": 1743537601, "exchange": "NMS", "messageBoardId": "finmb_9425271", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 131.87, "marketState": "CLOSED", "shortName": "Intra-Cellular Therapies Inc.", "longName": "Intra-Cellular Therapies, Inc.", "displayName": "Intra-Cellular Therapies", "trailingPegRatio": null, "__fetch_time": "2025-04-12"}]